Wilms' Tumor Protein 1 and Enzymatic Oxidation of 5-Methylcytosine in Brain Tumors: Potential Perspectives

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2018 Apr 7

PMID 29623275

Citations 3

Authors

Ashley Ramsawhook

Alexey Ruzov

Beth Coyle

Affiliations

Soon will be listed here.

Abstract

The patterns of 5-methylcytosine (5mC) and its oxidized derivatives, 5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxylcytosine (5caC) are reportedly altered in a range of cancers. Likewise, Wilms' Tumor protein 1 (WT1), a transcription factor essential for urogenital, epicardium, and kidney development exhibits aberrant expression in multiple tumors. Interestingly, WT1 directly interacts with TET proteins that catalyze the enzymatic oxidation of 5mC and exhibits high affinity for 5caC-containing DNA substrates . Here we review recent developments in the fields of Tet-dependent 5mC oxidation and WT1 biology and explore potential perspectives for studying the interplay between TETs and WT1 in brain tumors.

Citing Articles

Delineating the glioblastoma stemness by genes involved in cytoskeletal rearrangements and metabolic alterations.

Kaluzinska-Kolat Z, Kolat D, Kosla K, Pluciennik E, Bednarek A World J Stem Cells. 2023; 15(5):302-322.

PMID: 37342224 PMC: 10277965. DOI: 10.4252/wjsc.v15.i5.302.

DNA 5-hydroxymethylcytosine in pediatric central nervous system tumors may impact tumor classification and is a positive prognostic marker.

Azizgolshani N, Petersen C, Chen Y, Levy J, Salas L, Perreard L Clin Epigenetics. 2021; 13(1):176.

PMID: 34538273 PMC: 8451154. DOI: 10.1186/s13148-021-01156-9.

WT1 Clone 6F-H2 Cytoplasmic Expression Differentiates Astrocytic Tumors from Astrogliosis and Associates with Tumor Grade, Histopathology, IDH1 Status, Apoptotic and Proliferative Indices: A Tissue Microarray Study.

Abd El-hafez A, Hany H Asian Pac J Cancer Prev. 2020; 21(8):2403-2413.

PMID: 32856872 PMC: 7771928. DOI: 10.31557/APJCP.2020.21.8.2403.

References

Hohenstein P, Hastie N . The many facets of the Wilms' tumour gene, WT1. Hum Mol Genet. 2006; 15 Spec No 2:R196-201. DOI: 10.1093/hmg/ddl196. View

Ladomery M, Dellaire G . Multifunctional zinc finger proteins in development and disease. Ann Hum Genet. 2002; 66(Pt 5-6):331-42. DOI: 10.1017/S0003480002001215. View

Baylin S . DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol. 2005; 2 Suppl 1:S4-11. DOI: 10.1038/ncponc0354. View

Thakkar J, Dolecek T, Horbinski C, Ostrom Q, Lightner D, Barnholtz-Sloan J . Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev. 2014; 23(10):1985-96. PMC: 4185005. DOI: 10.1158/1055-9965.EPI-14-0275. View

Kim G, Ni J, Kelesoglu N, Roberts R, Pradhan S . Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J. 2002; 21(15):4183-95. PMC: 126147. DOI: 10.1093/emboj/cdf401. View

Ramsawhook A, Lewis L, Coyle B, Ruzov A . Medulloblastoma and ependymoma cells display increased levels of 5-carboxylcytosine and elevated expression. Clin Epigenetics. 2017; 9:18. PMC: 5307644. DOI: 10.1186/s13148-016-0306-2. View

Roberts S . Transcriptional regulation by WT1 in development. Curr Opin Genet Dev. 2005; 15(5):542-7. DOI: 10.1016/j.gde.2005.08.004. View

Orr B, Haffner M, Nelson W, Yegnasubramanian S, Eberhart C . Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma. PLoS One. 2012; 7(7):e41036. PMC: 3400598. DOI: 10.1371/journal.pone.0041036. View

Grosfeld J . Risk-based management: current concepts of treating malignant solid tumors of childhood. J Am Coll Surg. 1999; 189(4):407-25. DOI: 10.1016/s1072-7515(99)00167-2. View

10.

Schittenhelm J, Mittelbronn M, Nguyen T, Meyermann R, Beschorner R . WT1 expression distinguishes astrocytic tumor cells from normal and reactive astrocytes. Brain Pathol. 2008; 18(3):344-53. PMC: 8095516. DOI: 10.1111/j.1750-3639.2008.00127.x. View

11.

Huang L, Mokkapati S, Hu Q, Ruteshouser E, Hicks M, Huff V . Nephron Progenitor But Not Stromal Progenitor Cells Give Rise to Wilms Tumors in Mouse Models with β-Catenin Activation or Wt1 Ablation and Igf2 Upregulation. Neoplasia. 2016; 18(2):71-81. PMC: 5005262. DOI: 10.1016/j.neo.2015.12.001. View

12.

Hastie N . Wilms' tumour 1 (WT1) in development, homeostasis and disease. Development. 2017; 144(16):2862-2872. DOI: 10.1242/dev.153163. View

13.

Konstandin N, Bultmann S, Szwagierczak A, Dufour A, Ksienzyk B, Schneider F . Genomic 5-hydroxymethylcytosine levels correlate with TET2 mutations and a distinct global gene expression pattern in secondary acute myeloid leukemia. Leukemia. 2011; 25(10):1649-52. DOI: 10.1038/leu.2011.134. View

14.

Takai H, Masuda K, Sato T, Sakaguchi Y, Suzuki T, Suzuki T . 5-Hydroxymethylcytosine plays a critical role in glioblastomagenesis by recruiting the CHTOP-methylosome complex. Cell Rep. 2014; 9(1):48-60. DOI: 10.1016/j.celrep.2014.08.071. View

15.

Hinoue T, Weisenberger D, Lange C, Shen H, Byun H, van den Berg D . Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res. 2011; 22(2):271-82. PMC: 3266034. DOI: 10.1101/gr.117523.110. View

16.

Mundlos S, Pelletier J, Darveau A, Bachmann M, Winterpacht A, Zabel B . Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues. Development. 1993; 119(4):1329-41. DOI: 10.1242/dev.119.4.1329. View

17.

Wilm B, Ipenberg A, Hastie N, Burch J, Bader D . The serosal mesothelium is a major source of smooth muscle cells of the gut vasculature. Development. 2005; 132(23):5317-28. DOI: 10.1242/dev.02141. View

18.

Herzer U, Crocoll A, Barton D, Howells N, Englert C . The Wilms tumor suppressor gene wt1 is required for development of the spleen. Curr Biol. 1999; 9(15):837-40. DOI: 10.1016/s0960-9822(99)80369-8. View

19.

Vize P, Seufert D, Carroll T, Wallingford J . Model systems for the study of kidney development: use of the pronephros in the analysis of organ induction and patterning. Dev Biol. 1997; 188(2):189-204. DOI: 10.1006/dbio.1997.8629. View

20.

Sturm D, Witt H, Hovestadt V, Khuong-Quang D, Jones D, Konermann C . Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell. 2012; 22(4):425-37. DOI: 10.1016/j.ccr.2012.08.024. View